- Published On: October 14, 2026
Wearable anaphylaxis detection is moving from research toward real life. Here is how these devices work, where the science stands, and what it means for allergy families today.
- October 7, 2026
Most airline medical kits carry epinephrine in glass ampules, not auto-injectors. Here is what the FAA's proposed rule says, what happened when 1,735 public comments came in, and how families can fly safer today.
- September 23, 2026
Serious reactions to IV contrast are uncommon, and nearly all begin within 20 minutes while you're still in the imaging department. Here's what actually predicts risk, why the shellfish myth is wrong, and what to tell your radiology team.
- September 16, 2026
A 504 plan does not follow a student to college, and the highest-risk years for fatal food reactions begin right as they leave home. Preparation covers campus dining, housing, roommates, and the emergency route.
- September 9, 2026
The FDA removed the age requirement from epinephrine nasal spray on March 26, 2026, so eligibility now rests on weight alone. Here is what that means for families of younger children, and what stays exactly the same in an emergency.
- September 2, 2026
Viaskin Peanut is an investigational skin patch that delivers small daily doses of peanut protein to desensitize children with peanut allergy, without swallowing anything or getting an injection. Phase 3 trial results show promising response rates, but the patch is not yet FDA approved and families still need a complete allergy action plan and epinephrine on hand.
- August 25, 2026
Anxiety and anaphylaxis share many physical symptoms, from a racing heart to nausea, making the two easy to confuse in a moment of crisis. This post breaks down how to tell them apart, why food allergies are linked to higher rates of anxiety, and why treating unclear symptoms as anaphylaxis is always the safer choice.







